Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples
International Journal of Molecular Sciences · 06.08.2023 · 24 (15) · 12489
DOI: 10.3390/ijms241512489 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.08.2023. Verfasst von Vincenzo Fiorentino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Pathology of the Adult and Developmental Age "G. Barresi", University of Messina, 98125 Messina, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bladder cancer and upper urothelial tract carcinoma are common diseases with a high risk of recurrence, thus necessitating follow-up after initial treatment. The management of non-muscle invasive bladder carcinoma (NMIBC) after transurethral resection involves surveillance, intravesical therapy, and cytology with cystoscopy. Urinary cytology, cystoscopy, and radiological evaluation of the upper urinary tract are recommended during follow-up in the international urological guidelines. Cystoscopy is the standard examination for the first assessment and follow-up of NMIBC, and urine cytology is a widely used urinary test with high sensitivity for high-grade urothelial carcinoma (HGUC) and carcinoma in situ (CIS). In recent years, various urinary assays, including DNA methylation markers, have been used to detect bladder tumors. Among these, the Bladder EpiCheck test is one of the most widely used and is based on analysis of the methylation profile of urothelial cells to detect bladder neoplasms. This review assesses the importance of methylation analysis and the Bladder EpiCheck test as urinary biomarkers for diagnosing urothelial carcinomas in patients in follow-up for NMIBC, helping cytology and cystoscopy in doubtful cases. A combined approach of cytology and methylation analysis is suggested not only to diagnose HGUC, but also to predict clinical and histological recurrences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Pathology of the Adult and Developmental Age "G. Barresi", University of Messina, 98125 Messina, Italy.
- PhD Programme in Translational Molecular Medicine and Surgery, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98125 Messina, Italy.
- Department of Women, Children and Public Health Sciences, Catholic University of the Sacred Heart, Agostino Gemelli IRCCS University Hospital Foundation, 00168 Rome, Italy.
- Department of Medicine and Surgery, Saint Camillus International University of Health and Medical Sciences (UniCamillus), 00131 Rome, Italy.
ORCID-Profile: Vincenzo Fiorentino, Cristina Pizzimenti, Maurizio Martini
Zitieren
APA
Fiorentino, V., Pizzimenti, C., Franchina, M., Rossi, E. D., Tralongo, P., Carlino, A., Larocca, L. M., Martini, M., Fadda, G., & Pierconti, F. (2023). Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. International Journal of Molecular Sciences, 24(15), 12489. https://doi.org/10.3390/ijms241512489
Vancouver
Fiorentino V, Pizzimenti C, Franchina M, Rossi ED, Tralongo P, Carlino A, et al. Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. International Journal of Molecular Sciences. 2023;24(15):12489. doi:10.3390/ijms241512489
BibTeX
@article{Fiorentino2023,
author = {Fiorentino, Vincenzo and Pizzimenti, Cristina and Franchina, Mariausilia and Rossi, Esther Diana and Tralongo, Pietro and Carlino, Angela and Larocca, Luigi Maria and Martini, Maurizio and Fadda, Guido and Pierconti, Francesco},
title = {Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {15},
pages = {12489},
doi = {10.3390/ijms241512489}
}
EUVIMED